Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EED | O75530 | 5/20 | 1.00 |
| ▸ | SUZ12 | Q15022 | 5/20 | 1.00 |
| ▸ | EZH2 | Q15910 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | CES2 | O00748 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | EPAS1 | Q99814 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | CES1 | P23141 | 2/20 | 1.00 |
| ▸ | PTPN6 | P29350 | 2/20 | 1.00 |
| ▸ | PTPN11 | Q06124 | 2/20 | 1.00 |
| ▸ | NSD1 | Q96L73 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16023777 | 0.91 | EED (0.84) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| SCHEMBL29538928 | 0.91 | EED (0.84) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| SCHEMBL16152326 | 0.88 | EED (0.78) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| Przewaquinone A SCHEMBL16152272 | 0.85 | IDO1 (1.00) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| Tanshinone Iib SCHEMBL14417728 | 0.84 | EED (1.00) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| Tanshinone Iib SCHEMBL11945767 | 0.84 | EED (1.00) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| Methyl Tanshinonate SCHEMBL14417730 | 0.83 | EED (1.00) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| SCHEMBL17663613 | 0.83 | EED (0.77) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| Methyl Tanshinonate SCHEMBL16152293 | 0.83 | EED (1.00) | EEDSUZ12EZH2MEN1ALDH1A1 | |
| SCHEMBL14417696 | 0.82 | EED (0.76) | EEDSUZ12EZH2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075435-A | Brain-targeted neutral granulocyte membrane-encapsulated tanshinone IIa PLGA nano preparation and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122067093-A | Multi-source remote sensing image-based dual-target prediction method for yield-quality of red sage root | 河南大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122059742-A | Compound foliar fertilizer, preparation method and application thereof | 易博生物科技(青岛)有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122005659-A | Pharmaceutical composition for treating burns and scalds in intensive care and preparation method thereof | 养系列(山东)生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005655-A | Magnetic nano-drug carrier | 中国中医科学院广安门医院 | 2026-05-12 | — | — | CN | claimed |
| CN-122011116-A | Salvia SmCLE-3 polypeptide and preparation method and application thereof | 易博生物科技(青岛)有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | claimed |
| US-20260061062-A1 | MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM | UNIV NEBRASKA (US) | 2026-03-05 | — | — | US | claimed |
| CN-121583384-A | Nucleic acid-small molecule non-covalent complex and preparation method and application thereof | 上海中医药大学 | 2026-02-27 | — | — | CN | claimed |
| US-12496349-B2 | Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2025-12-16 | — | — | US | claimed |
| CN-112345679-B | Fingerprint characteristic spectrum of Wuling preparation, establishing method and application thereof | 清华德人西安幸福制药有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-111667889-B | Method for predicting content of quality marker in salvia miltiorrhiza | 山东中医药大学 | 2022-03-01 | — | — | CN | claimed |
| CN-114081990-A | Traditional Chinese medicine composite temperature-sensitive gel embolic agent as well as preparation method and application thereof | 江苏省中医药研究院 | 2022-02-25 | — | — | CN | claimed |
| CN-114085264-A | A method for preparing tanshinone IIA extracted from Saviae Miltiorrhizae radix | 河南省康华药业股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-110907576-B | Method for simultaneously determining content of 16 active ingredients in Guanxinjing capsule | 河北医科大学 | 2022-02-11 | — | — | CN | claimed |
| CN-113975264-A | Method for preventing or treating side effects of tumor therapy | 上海岸阔医药科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113980087-A | Method for preparing tanshinone IIA sodium sulfonate | 上海上药第一生化药业有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113967267-A | Endoplasmic reticulum targeting of fatty acid modified albumin and uses thereof | 四川大学 | 2022-01-25 | — | — | CN | claimed |
| WO-2016160880-A1 | METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS | BAYLOR RESEARCH INSTITUTE (US) | 2016-10-06 | — | — | WO | claimed |
| WO-2015194710-A1 | COMPOSITION COMPRISING MESENCHYMAL STEM CELLS TREATED WITH STAT3 INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING IMMUNE DISEASES | 가톨릭대학교 산학협력단 | 2015-12-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260061062-A1 | MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM | CD44, ALG1, HSF1 | EED 4656/4885SUZ12 4677/4885EZH2 3726/4885 |
| US-12496349-B2 | Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform | PLG, PYGL, PPIG | EED 4846/4885SUZ12 4840/4885EZH2 4613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.